Concepedia

Calvin S. R. Gooden

CS

5

Publications

293

Citations

5

H-Index

1990

Active since

Affiliations

Hammersmith Hospital(Current)

Calvin S. R. Gooden is an author at Hammersmith Hospital specializing in medicine, immunology, and cancer research.

Top concepts

MedicinePathologyImmunologyCancer ResearchRadiation OncologyTumor MicroenvironmentHealthAllergyOncologyRadiology

Publications per year

1990–1998

5

Publications

5

Development of humoral immune responses against a macrocyclic chelating agent (DOTA) in cancer patients receiving radioimmunoconjugates for imaging and therapy.

Christos Kosmas, D Snook, Calvin S. R. Gooden et al. · PubMed · 1992 · 85 citations

Humoral Immune Responses, Immunology, Pathology +19

Radioimmunotherapy after chemotherapy compared to chemotherapy alone in the treatment of advanced ovarian cancer: a matched analysis.

Steve Nicholson, Calvin S. R. Gooden, V Hird et al. · Oncology Reports · 1998 · 83 citations

Distribution of intestinal mast cell proteinase in blood and tissues of normal and <i>Trichinella‐intected</i> mice

John F. Huntley, Calvin S. R. Gooden, G. F. J. NEWLANDS et al. · Parasite Immunology · 1990 · 68 citations

Mucosal Mast Cell, Autoimmune Disease, Allergy +14

Tumour localisation with a radioactively labelled reshaped human monoclonal antibody

V Hird, Martine Verhoeyen, R.A. Badley et al. · British Journal of Cancer · 1991 · 37 citations · Full text

Tumor Biology, Immunocytochemical Technique, Human Monoclonal Antibody +10

Anti-chelate antibodies after intraperitoneal yttrium-90-labeled monoclonal antibody immunoconjugates for ovarian cancer therapy.

Christos Kosmas, Anthony Maraveyas, Calvin S. R. Gooden et al. · PubMed · 1995 · 20 citations

Rows per page

1–5 of 5